Trump signs executive order to demand pharma industry cuts prices By Steve Holland, Michael Erman and Patrick Wingrove Reuters May 12, 2025 WASHINGTON â€� President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicin…
FDA names agency critic Prasad as top vaccine official By Dan Levine and Julie Steenhuysen Reuters May 6, 2025 U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has criticized FDA leadership and COVID-19 mandates, as director o…
Pharma imports surged in March By Michael Erman Reuters May 6, 2025 NEW YORK â€� Pharmaceutical imports to the U.S. surged in March, as drugmakers stocked up in advance of potential tariffs on their products, whi…
Medicine companies brace for tariffs, while weighing additional concern By Reuters Apr 24, 2025 Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they grapple with the thr…
Drugmakers agree to participate in second round of price negotiation By Reuters Mar 14, 2025 All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second round of price talks have agre…
Cigna taking steps to lower out-of-pocket cost of prescription drugs Jan 29, 2025 (Reuters) -Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as it resp…
Trump's administration aims for 'greater transparency' in drug price negotiations Jan 29, 2025 (Reuters) - The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President D…
Ozempic, Wegovy picked for Medicare price negotiations By Michael Erman, Ahmed Aboulenein and Bhanvi Satija Reuters Jan 17, 2025 Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiati…
Drug companies to raise prices on 250 medicine products By Michael Erman Reuters Dec 31, 2024 NEW YORK â€� Drug companies plan to raise U.S. prices on at least 250 branded medications, including Pfizer COVID-19 treatment Paxlovid, Bristol…
Utah sues pharmacy benefit managers, claming they flooded state with opioids By Kyle Dunphey Utah News Dispatch Dec 26, 2024 Utah filed a lawsuit this week targeting companies it says are responsible for fueling the country’s opioid crisis.  Â
